Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend cash

.Turnstone Biologics is decreasing its headcount through 60% as well as shocking its C-suite if you ...

Gilead gives up on $15M MASH bet after reviewing preclinical data

.In a year that has actually seen an approval and also a plethora of readouts for metabolic dysfunct...

Texas biotech centers cancer pact, pins really hopes on weight problems

.Alaunos Rehabs is actually axing a deal with Precigen, surrendering licensing rights to a customize...

Capricor portions a lot more information for DMD therapy after starting BLA

.Capricor Rehabs is actually taking a success lap for their stage 2 Duchenne muscle dystrophy (DMD) ...

FDA locations Kezar lupus test in grip following 4 client fatalities

.The FDA has positioned Kezar Life Sciences' lupus test on hold after the biotech flagged four death...

Phase 3 Intellectual Rock trial reaches SMA objective, sending stock up 200%

.A phase 3 test of Intellectual Stone's spine muscle atrophy (SMA) prospect has reached its main end...

CAMP 4 is newest to eye IPO, while Upstream describe $182M planning

.RNA biotech CAMP4 Therapies has marked out plans for a $67 million IPO, with inflammation-focused U...

Galecto gets leukemia medicine, goes down bone cancer cells possession in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis applicant sent out Galecto on a sear...

Judo tosses down $100M to knock senseless kidney ailment

.Taking the mat is actually Judo Biography, an ambitious biotech armed along with $100 million to es...

AstraZeneca spends CSPC $100M for preclinical heart disease drug

.AstraZeneca has actually paid off CSPC Drug Group $one hundred thousand for a preclinical cardiovas...